References
- Kris M G, Gralla R J, Tyson L B, et al. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide dexamethasone and diphenhydramine. Cancer 1985; 55: 527–34
- Aasebø U, Slørdal L, Prytz P S, Aarbakke J. High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesis. Pharmacol Toxicol 1987; 60: 337–9
- Nelson J C, Tindall D J. A comparison of the adrenal responses to hypoglycemia, metyrapone and ACTH. Am J Med Sci 1978; 275: 165–6
- Aasebø U, Slørdal L, Aanderud S, Aakvaag A. Chemotherapy and endocrine function in lung cancer. Acta Oncol 1989; 28: 667–9
- Alberola V, Garcia J, Lluch A, et al. Relationship between adrenal failure and delayed emesis in patients receiving dexamethasone to prevent gastrointestinal toxicity of high-dose cisplatin. Cancer Chemother Pharmacol 1986; 18(Suppl 1)A2
- Gralla R J. Metoclopramide. A review of antiemetic trials. Drugs 1983; 25(Suppl 1)63–73